文章摘要
任孝颖,江玉洁,张雅惠,潘鑫涛,王重建,李琳琳,霍文倩,李玉倩,张振中,刘晓田.血浆外泌体差异表达微小RNA与2型糖尿病的关联研究[J].中华流行病学杂志,2026,47(2):356-361
血浆外泌体差异表达微小RNA与2型糖尿病的关联研究
Association of differentially expressed microRNAs in plasma exosomes and type 2 diabetes mellitus
收稿日期:2025-06-16  出版日期:2026-02-13
DOI:10.3760/cma.j.cn112338-20250616-00401
中文关键词: 血浆外泌体  糖尿病, 2型  微小RNA表达谱  病例对照研究
英文关键词: Plasma exosome  Diabetes mellitus, type 2  microRNA profile  Case-control study
基金项目:河南省重点研发与推广专项(232102311129);中国博士后科学基金(2020M672297);国家自然科学基金青年项目(82003543);国家重点研发计划“精准医学研究”重点专项(2016YFC0900803)
作者单位E-mail
任孝颖 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
江玉洁 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
张雅惠 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
潘鑫涛 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
王重建 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
李琳琳 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
霍文倩 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001  
李玉倩 郑州大学药学院临床药学系, 郑州 450001  
张振中 郑州大学药学院临床药学系, 郑州 450001  
刘晓田 郑州大学公共卫生学院流行病与卫生统计学系, 郑州 450001
河南省肿瘤流行病学重点实验室, 郑州 450001
河南省肿瘤生物标志物与分子成像国际联合实验室, 郑州 450001 
xtliu2008@126.com 
摘要点击次数: 1578
全文下载次数: 456
中文摘要:
      目的 描述2型糖尿病(T2DM)病例血浆外泌体微小RNA(miRNA)表达谱,探讨miR-122-5p的相对表达水平与T2DM的关联。方法 采用病例对照研究设计,病例组来自河南农村队列2020年随访时依据FPG新诊断的T2DM病例,按照同性别、同村、年龄相差≤3岁的原则,进行1∶1匹配对照。第一阶段发现集纳入5名新诊断的T2DM病例和5名对照,采用小RNA测序分析差异表达miRNA;第二阶段验证集共纳入72名新诊断的T2DM病例及72名对照,通过实时荧光定量PCR检测血浆外泌体miR-122-5p相对表达水平。连续变量采用t检验或Wilcoxon秩和检验,分类变量采用χ2检验比较病例组和对照组之间的分布差异,使用logistic回归和广义线性模型分析血浆外泌体miR-122-5p的相对表达水平与T2DM及糖代谢指标之间的关联。结果 发现集测序发现117个差异表达的miRNA,其中miR-122-5p在T2DM病例中表达上调(log2表达量差异倍数=2.12,P<0.001),且其平均表达量位列首位。验证集发现血浆外泌体miR-122-5p在T2DM病例中的表达量(6.26)高于对照(5.82),差异有统计学意义(P=0.018),调整混杂因素后,外泌体miR-122-5p相对表达水平每升高1个单位,T2DM的患病风险增加40.8%(OR=1.408,95%CI:1.002~1.978),且与胰岛素抵抗标志物甘油三酯葡萄糖指数呈正相关(β=0.115,95%CI:0.009~0.221)。结论 T2DM病例血浆外泌体miRNA表达变化明显,miR-122-5p的相对表达水平在T2DM病例中上调,且与T2DM的患病风险呈正相关。
英文摘要:
      Objective To characterize the plasma exosomal microRNA (miRNA) profile in type 2 diabetes mellitus (T2DM) patients and investigate the association of exosomal miR-122-5p expression with the disease. Methods This study was a case-control study, and the case group was drawn from the Henan Rural Cohort and comprised T2DM patients newly diagnosed based on FPG. A 1∶1 matched control group was formed according to the principle of the same gender, same village, and age ± 3 years. The first-phase discovery set included five newly diagnosed T2DM patients and five controls, and the second-phase validation set included 72 newly diagnosed T2DM and 72 controls. miRNA profiling of plasma exosomes was performed by next-generation RNA sequencing in the discovery sets to identify differentially expressed miRNAs. Quantitative real-time PCR was used to detect the relative expression level of plasma exosomal miR-122-5p. Continuous variables were compared between the case and control groups using a t-test or a Wilcoxon rank-sum test, and categorical variables were compared using a χ2 test for distribution differences. The association between plasma exosomal miR-122-5p and T2DM, as well as glucose metabolism indicators, was analyzed using logistic regression and generalized linear models. Results Discovery set sequencing revealed 117 differentially expressed miRNAs, among which miR-122-5p was upregulated in the T2DM patients (log2fold change=2.12, P<0.001), and its average expression level ranked first. The validation set found that plasma exosomal miR-122-5p was upregulated in patients with T2DM (6.26) compared to controls (5.82) with a statistically significant difference (P=0.018). After adjusting for confounding factors, the risk of T2DM increased by 40.8% (OR=1.408, 95%CI: 1.002-1.978) for every 1 unit increase in the relative expression level of exosomal miR-122-5p. It was positively correlated with the insulin resistance marker triglyceride-glucose index (β=0.115, 95%CI: 0.009- 0.221). Conclusions This study demonstrated significant changes in plasma exosomal miRNA in patients with T2DM. Among them, the relative expression level of plasma exosomal miR-122-5p was upregulated in patients with T2DM and was positively correlated with the risk of T2DM.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭